Is antihistamine (anti-allergic medication) helpful in treating viral upper respiratory tract infections (URTI) in toddlers?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 14, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Antihistamines Are Not Helpful for Viral Colds in Toddlers

Antihistamines should not be used to treat viral upper respiratory tract infections (common colds) in toddlers, as they provide no clinically meaningful benefit and carry potential risks in this age group. 1, 2

Evidence Against Antihistamine Use

Lack of Efficacy in Children

  • The European Position Paper on Rhinosinusitis and Nasal Polyps (EPOS 2020) explicitly states that antihistamines show no additive effect over standard treatment in children with post-viral acute rhinosinusitis, based on level 1b evidence. 1

  • A comprehensive Cochrane systematic review found no evidence of effectiveness of antihistamines in children with the common cold. 3

  • In adults, antihistamines showed only minimal short-term benefit (days 1-2) on overall symptom severity, but no clinically significant effect on specific symptoms like nasal congestion, rhinorrhea, or sneezing. 3

Potential Harms in Young Children

  • The FDA's Nonprescription Drugs and Pediatric Advisory Committees recommended that over-the-counter cough and cold medications, including antihistamines, no longer be used for children below 6 years of age. 4

  • Between 1969 and 2006, there were 54 documented fatalities associated with decongestants in children under 6 years, with 43 deaths occurring in infants under 1 year. 4

  • The FDA does not recommend the use of cough and cold products containing antihistamines in children younger than 2 years. 5

Mechanism of Potential Harm

  • Antihistamines may actually worsen congestion by drying the nasal mucosa in patients without an allergic component to their illness. 2

  • First-generation antihistamines carry additional risks of sedation and impairment of cognitive and academic function in children. 6, 7

When Antihistamines Might Be Considered (Exception)

  • Antihistamines may only be appropriate if the toddler has a documented allergic component (such as known allergic rhinitis) contributing to their symptoms, not for the viral cold itself. 2, 6

  • In such cases, second-generation antihistamines (cetirizine or loratadine) are preferred over first-generation options due to reduced sedation and cognitive effects. 6, 7

  • For children under 5 years of age, only cetirizine and loratadine are approved. 6

Recommended Approach for Viral Colds in Toddlers

  • Viral rhinosinusitis is self-limiting and typically resolves without specific treatment. 2

  • Nasal saline irrigation may improve quality of life and decrease symptoms without medication risks. 2

  • Supportive care remains the cornerstone of management in this age group. 1

Critical Pitfall to Avoid

Do not prescribe antihistamines for toddlers with viral colds simply because parents request "something to help" or because these medications are available over-the-counter. The evidence clearly demonstrates lack of benefit and potential for harm in this vulnerable population. 4, 3, 5

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Role of Antihistamines in Viral Rhinosinusitis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Antihistamines for the common cold.

The Cochrane database of systematic reviews, 2015

Guideline

Nasal Drops in Children and Infants: Safety Considerations

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

The Use and Safety of Cough and Cold Medications in the Pediatric Population.

The journal of pediatric pharmacology and therapeutics : JPPT : the official journal of PPAG, 2025

Research

Clinical prescribing of allergic rhinitis medication in the preschool and young school-age child: what are the options?

BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy, 2001

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.